PCSA

Processa Pharmaceuticals, Inc. NCM · PCSA

$2.31 +0.07 (+3.12%)

Neutral · +0.64σ

+ Compare Open in Sniper

Valuation

Market cap $0.0B

P/E (ttm) —

Forward P/E -0.6

Beta (5y) 0.99

Shares out 2.8M

Div yield —

Profitability & returns

ROE -465.0%

Net margin —

FCF margin —

Debt / equity —

Trading information

Last price $2.31

Day range $2.18 – $2.34

52-wk range $1.67 – $3.48

Avg volume 0.1M

RSI (2) 61.5

Trend zone Neutral

52-week range · today's price

$1.67$3.48

Company

Sector Healthcare

Industry Biotechnology

Exchange NCM

Next earnings —

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells. Its oncology pip…